_id
69131320ccc777a4e85d7f7d
Ticker
MBCOF
Name
Marvel Biosciences Corp.
Exchange
PINK
Address
505 8th Avenue S.W., Calgary, AB, Canada, T2P 1G2
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://marvelbiotechnology.com
Description
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Last Close
0.1017
Volume
2000
Current Price
0.1051
Change
0.0041
Last Updated
2026-01-05T10:09:17.287Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
5899055
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.732
Sentiment Sources
1
Current Quarter
2025-10-31
Revenue
0
Cost Of Revenue
57457
Gross Profit
-57457
Operating Expenses
263357
Operating Income
-263357
Interest Expense
56400
Pretax Income
-342263
Net Income
-342263
Eps
-0.005951936163027017
Dividends Per Share
-
Shares Outstanding
58004481
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-22506
Cash
633536
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
683056
Property Plant Equipment
-
Total Assets
683056
Payables
1607814
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4334833
Equity
-3651777
Bs_currency_symbol
CAD
Depreciation
-
Change In Working Capital
150221
Cash From Operations
-178457
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
683138
Net Change In Cash
504681
Cf_currency_symbol
CAD
PE
-
PB
-1.6550082201350191
ROE
9.372505495269836
ROA
-50.10760464734956
FCF
-178457
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2025-10-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
57457
Quarters > 0 > income Statement > gross Profit
-57457
Quarters > 0 > income Statement > operating Expenses
263357
Quarters > 0 > income Statement > operating Income
-263357
Quarters > 0 > income Statement > interest Expense
56400
Quarters > 0 > income Statement > pretax Income
-342263
Quarters > 0 > income Statement > net Income
-342263
Quarters > 0 > income Statement > eps
-0.005951936163027017
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
57504481
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-22506
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
633536
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
683056
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
683056
Quarters > 0 > balance Sheet > payables
1607814
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4334833
Quarters > 0 > balance Sheet > equity
-3651777
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-342263
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
150221
Quarters > 0 > cash Flow > cash From Operations
-178457
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
683138
Quarters > 0 > cash Flow > net Change In Cash
504681
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.005951936163027017
Quarters > 0 > ratios > PB
-1.6550082201350191
Quarters > 0 > ratios > ROE
9.372505495269836
Quarters > 0 > ratios > ROA
-50.10760464734956
Quarters > 0 > ratios > FCF
-178457
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-07-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
250559
Quarters > 1 > income Statement > gross Profit
-250559
Quarters > 1 > income Statement > operating Expenses
347987
Quarters > 1 > income Statement > operating Income
-347987
Quarters > 1 > income Statement > interest Expense
161771
Quarters > 1 > income Statement > pretax Income
-1190206
Quarters > 1 > income Statement > net Income
-1190206
Quarters > 1 > income Statement > eps
-0.022476338824926237
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
52953731
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-680520
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
128855
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
326715
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
326715
Quarters > 1 > balance Sheet > payables
1500303
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4332952
Quarters > 1 > balance Sheet > equity
-4006237
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-1190206
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
148025
Quarters > 1 > cash Flow > cash From Operations
-330145
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
69984
Quarters > 1 > cash Flow > net Change In Cash
-260161
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.022476338824926237
Quarters > 1 > ratios > PB
-1.389193182555101
Quarters > 1 > ratios > ROE
29.708826512260757
Quarters > 1 > ratios > ROA
-364.2948747379214
Quarters > 1 > ratios > FCF
-330145
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-04-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
382
Quarters > 2 > income Statement > gross Profit
-382
Quarters > 2 > income Statement > operating Expenses
275321
Quarters > 2 > income Statement > operating Income
-275321
Quarters > 2 > income Statement > interest Expense
34652
Quarters > 2 > income Statement > pretax Income
-257411
Quarters > 2 > income Statement > net Income
-257411
Quarters > 2 > income Statement > eps
-0.004930892774694591
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
52203731
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
50700
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
389016
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
500512
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
500512
Quarters > 2 > balance Sheet > payables
1392279
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
710000
Quarters > 2 > balance Sheet > total Liabilities
3426223
Quarters > 2 > balance Sheet > equity
-2925711
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-257411
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-291561
Quarters > 2 > cash Flow > cash From Operations
-531314
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
860800
Quarters > 2 > cash Flow > net Change In Cash
329486
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.004930892774694591
Quarters > 2 > ratios > PB
-1.8753089857815757
Quarters > 2 > ratios > ROE
8.798237419895539
Quarters > 2 > ratios > ROA
-51.429536154977306
Quarters > 2 > ratios > FCF
-531314
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2025-01-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
285002
Quarters > 3 > income Statement > gross Profit
-285002
Quarters > 3 > income Statement > operating Expenses
393395
Quarters > 3 > income Statement > operating Income
-393395
Quarters > 3 > income Statement > interest Expense
35795
Quarters > 3 > income Statement > pretax Income
-485606
Quarters > 3 > income Statement > net Income
-485606
Quarters > 3 > income Statement > eps
-0.010838516997613436
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
44803731
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-56416
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
59530
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
219075
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
219075
Quarters > 3 > balance Sheet > payables
1745376
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
1710000
Quarters > 3 > balance Sheet > total Liabilities
3765833
Quarters > 3 > balance Sheet > equity
-3546758
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-485606
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
440433
Quarters > 3 > cash Flow > cash From Operations
-26383
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2625
Quarters > 3 > cash Flow > net Change In Cash
-23758
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.010838516997613436
Quarters > 3 > ratios > PB
-1.3276553201825443
Quarters > 3 > ratios > ROE
13.691545913197348
Quarters > 3 > ratios > ROA
-221.66198790368594
Quarters > 3 > ratios > FCF
-26383
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2025-07-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
547366
Annuals > 0 > income Statement > gross Profit
-547366
Annuals > 0 > income Statement > operating Expenses
1248683
Annuals > 0 > income Statement > operating Income
-1248683
Annuals > 0 > income Statement > interest Expense
268006
Annuals > 0 > income Statement > pretax Income
-2211468
Annuals > 0 > income Statement > net Income
-2211468
Annuals > 0 > income Statement > eps
-0.041762269782274646
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
52953731
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-696713
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
128855
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
326715
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
326715
Annuals > 0 > balance Sheet > payables
1500303
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4332952
Annuals > 0 > balance Sheet > equity
-4006237
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-2211468
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
291179
Annuals > 0 > cash Flow > cash From Operations
-1150323
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
933409
Annuals > 0 > cash Flow > net Change In Cash
-216914
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.041762269782274646
Annuals > 0 > ratios > PB
-1.3442525848321005
Annuals > 0 > ratios > ROE
55.2006284201359
Annuals > 0 > ratios > ROA
-676.8798494100363
Annuals > 0 > ratios > FCF
-1150323
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-07-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
302023
Annuals > 1 > income Statement > gross Profit
-302023
Annuals > 1 > income Statement > operating Expenses
1271884
Annuals > 1 > income Statement > operating Income
-1271884
Annuals > 1 > income Statement > interest Expense
113977
Annuals > 1 > income Statement > pretax Income
-1650079
Annuals > 1 > income Statement > net Income
-1650079
Annuals > 1 > income Statement > eps
-0.036843444137998574
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
44786231
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-264218
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
345769
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
491311
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
491311
Annuals > 1 > balance Sheet > payables
1347884
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
1710000
Annuals > 1 > balance Sheet > total Liabilities
3317115
Annuals > 1 > balance Sheet > equity
-2825804
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-1650079
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
184863
Annuals > 1 > cash Flow > cash From Operations
-1179496
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
968643
Annuals > 1 > cash Flow > net Change In Cash
-210853
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.036843444137998574
Annuals > 1 > ratios > PB
-1.6118455818945687
Annuals > 1 > ratios > ROE
58.393257281821384
Annuals > 1 > ratios > ROA
-335.8522402307296
Annuals > 1 > ratios > FCF
-1179496
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2023-07-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
887516
Annuals > 2 > income Statement > gross Profit
-887516
Annuals > 2 > income Statement > operating Expenses
2248185
Annuals > 2 > income Statement > operating Income
-2248185
Annuals > 2 > income Statement > interest Expense
38422
Annuals > 2 > income Statement > pretax Income
-2291389
Annuals > 2 > income Statement > net Income
-2291389
Annuals > 2 > income Statement > eps
-0.05759251234428313
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
39786231
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-4782
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
556622
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
672389
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
672389
Annuals > 2 > balance Sheet > payables
1208440
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
1000000
Annuals > 2 > balance Sheet > total Liabilities
2392477
Annuals > 2 > balance Sheet > equity
-1720088
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-2291389
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
879039
Annuals > 2 > cash Flow > cash From Operations
-1332235
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1295650
Annuals > 2 > cash Flow > net Change In Cash
-36585
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.05759251234428313
Annuals > 2 > ratios > PB
-2.3523562124147137
Annuals > 2 > ratios > ROE
133.21347512452851
Annuals > 2 > ratios > ROA
-340.7832370844853
Annuals > 2 > ratios > FCF
-1332235
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2022-07-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1377160
Annuals > 3 > income Statement > gross Profit
-1377160
Annuals > 3 > income Statement > operating Expenses
2548279
Annuals > 3 > income Statement > operating Income
-2548279
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-2554139
Annuals > 3 > income Statement > net Income
-2554139
Annuals > 3 > income Statement > eps
-0.06887027694995482
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
37086231
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-2548127
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-4311
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
593207
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
56438
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
913541
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
913541
Annuals > 3 > balance Sheet > payables
262095
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
718005
Annuals > 3 > balance Sheet > equity
195536
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2554139
Annuals > 3 > cash Flow > depreciation
152
Annuals > 3 > cash Flow > change In Working Capital
360050
Annuals > 3 > cash Flow > cash From Operations
-2193937
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
394000
Annuals > 3 > cash Flow > net Change In Cash
-1799937
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.06887027694995482
Annuals > 3 > ratios > PB
19.288876179833892
Annuals > 3 > ratios > ROE
-1306.224429261108
Annuals > 3 > ratios > ROA
-279.58668521719335
Annuals > 3 > ratios > FCF
-2193937
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
8
Valuation > metrics > PE
-0.005951936163027017
Valuation > metrics > PB
-1.6550082201350191
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
9.372505495269836
Profitability > metrics > ROA
-50.10760464734956
Profitability > final Score
34
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-4.669450354609929
Risk > final Score
11
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.42483521103809274
Liquidity > metrics > Quick Ratio
0.42483521103809274
Liquidity > final Score
31
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
33
Prev Profitabilities > 2
42
Prev Risks > 0
21
Prev Risks > 1
-2
Prev Risks > 2
-14
Prev Liquidities > 0
21
Prev Liquidities > 1
28
Prev Liquidities > 2
16
Updated At
2026-01-20T22:10:52.176Z
Earnings History > 0 > period
2026-01-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2026-01-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-10-31
Earnings History > 1 > report Date
2025-12-18
Earnings History > 1 > date
2025-10-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0044
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-07-31
Earnings History > 2 > report Date
2025-07-31
Earnings History > 2 > date
2025-07-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0164
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-04-30
Earnings History > 3 > report Date
2025-04-30
Earnings History > 3 > date
2025-04-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0039
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-01-31
Earnings History > 4 > report Date
2025-03-31
Earnings History > 4 > date
2025-01-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0076
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-10-31
Earnings History > 5 > report Date
2024-12-16
Earnings History > 5 > date
2024-10-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0046
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-07-31
Earnings History > 6 > report Date
2024-07-31
Earnings History > 6 > date
2024-07-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0096
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-04-30
Earnings History > 7 > report Date
2024-04-30
Earnings History > 7 > date
2024-04-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0057
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-10-31
Earnings History > 8 > report Date
2023-12-18
Earnings History > 8 > date
2023-10-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0096
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-07-31
Earnings History > 9 > report Date
2023-07-31
Earnings History > 9 > date
2023-07-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0197
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AToronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite - Investing News Network
12/22/2025
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite Investing News Network
Read more →(Last Updated 2025-10-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Marvel Biosciences Corp.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-01-31
EPS Estimate
—
Date
2025-10-31
EPS Actual
-0.0044
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-10-31)
(Last Updated 2025-10-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-10-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-10-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.